SMORF(SMORF)
SMORF
No analyst ratings available
No analyst price targets available for SMORF
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $17.00B | $19.43B | $21.56B |
| Low | $15.73B | $18.14B | $20.05B |
| High | $18.19B | $20.30B | $22.78B |
| EBITDA Avg | $4.04B | $4.62B | $5.13B |
| Low | $3.74B | $4.31B | $4.77B |
| High | $4.32B | $4.83B | $5.42B |
| EBIT Avg | $3.72B | $4.26B | $4.72B |
| Low | $3.45B | $3.97B | $4.39B |
| High | $3.99B | $4.45B | $4.99B |
| Net Income Avg | $1.48B | $2.04B | $2.65B |
| Low | $1.34B | $1.86B | $2.41B |
| High | $1.58B | $2.19B | $2.84B |
| EPS Avg | $0.24 | $0.33 | $0.43 |
| Low | $0.22 | $0.30 | $0.39 |
| High | $0.25 | $0.35 | $0.46 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 4 / 1 |